Kardi Trading Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
- Revenue Growth 31.98%
- Profit Growth 64.10%
- Ebitda -14.50%
- Net Worth 103.38%
- Total Assets 76.28%
About Kardi Trading
Kardi Trading Private Limited (KTPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 December 2018 (Six years and one month 27 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Sai Shaw and Ramchandraiah Metthati serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909TG2018PTC128909
-
Company No.
128909
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Dec 2018
-
Date of AGM
25 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Kardi Trading?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sai Shaw
|
Director | 10-Dec-2018 | Current |
|
Ramchandraiah Metthati
|
Director | 10-Dec-2018 | Current |
Financial Performance of Kardi Trading.
Kardi Trading Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.98% increase. The company also saw a substantial improvement in profitability, with a 64.1% increase in profit. The company's net worth Soared by an impressive increase of 103.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kardi Trading?
In 2023, Kardi Trading had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Celute Lifesciences Private LimitedSai Shaw is a mutual person
-
Nossam Farms Private Limited
Ramchandraiah Metthati is a mutual person
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jan 2023 | Others | ₹5.00 M | Open |
How Many Employees Work at Kardi Trading?
Unlock and access historical data on people associated with Kardi Trading, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kardi Trading, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kardi Trading's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.